Cybin Irl Limited collaborated with IntelGenx Corp. and introduced a dissolvable oral film that is dosed with psilocybin. This fast-acting film has the potential to increase both the safety and efficacy of psilocybin when administered in this manner, for treating major depressive disorders along with therapy.
COMPASS Pathways Plc., announced positive results regarding the usage of COMP360 psilocybin therapy in anorexia nervosa and severe treatment-resistant depression at the Society of Biological Psychiatry Annual Meeting in New Orleans, from two investigator-initiated studies.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?